Cell Technologies in the Treatment of Chronic Wounds in Patients with Diabetes Mellitus

  • Yu. V. Ivanova Kharkiv National Medical University, Kharkiv, Ukraine; Institute of Cellular Biorehabilitation, Kharkiv, Ukraine; Zaitsev Institute of General and Emergency Surgery of the National Academy of Medical Sciences of Ukraine, Kharkiv, Ukraine
  • S. M. Gramatiuk Institute of Cellular Biorehabilitation, Kharkiv, Ukraine; Zaitsev Institute of General and Emergency Surgery of the National Academy of Medical Sciences of Ukraine, Kharkiv, Ukraine
  • V. O. Prasol Kharkiv National Medical University, Kharkiv, Ukraine; Zaitsev Institute of General and Emergency Surgery of the National Academy of Medical Sciences of Ukraine, Kharkiv, Ukraine
  • K. V. Miasoiedov Kharkiv National Medical University, Kharkiv, Ukraine
  • O. O. Zarudnyi Zaitsev Institute of General and Emergency Surgery of the National Academy of Medical Sciences of Ukraine, Kharkiv, Ukraine
  • K. A. Holtsev Kharkiv National Medical University, Kharkiv, Ukraine
DOI: https://doi.org/10.30702/transpaorg/10_21.2710/1151-65/4.001.4
Keywords: diabetes mellitus, chronic wounds, mesenchymal stem cells, fibroblast matrix

Abstract

Materials and methods. The results of treatment of 8 patients with chronic wounds and diabetes mellitus (DM) type 2 and stage IV chronic ischemia of the lower extremities by Fontaine were analyzed, in 2 cases there was a combination of venous and arterial insufficiency. Revascularization of the lower extremities was performed through open (2), endovascular (4) and hybrid surgery (2). In case of venous insufficiency, sclerotherapy of perforator veins was performed.

After surgical treatment of the purulent focus, specific bacteriophages were used (after microflora identification). Hydrogel dressings were applied daily, alongside with transplantation of 5,000,000 mesenchymal stem cells (MSC) (CD73+, CD90+, CD105+ and CD45-, CD34-, CD14-, CD79-) by injection into muscle tissue around the wound, then the wound surface was closed with hMSC-fibroblast matrix.

Results. After the closure of the wound surface with fibroblast matrix, the patients noted the disappearance of the pain syndrome. The surface area of the wounds averaged 91.3 ± 30.42 cm 2 before the start of treatment, 89.8 ± 34.21 cm 2 on day 5 and – 73.95 ± 21.2 cm 2 on day 12. Spontaneous epithelialization was achieved in the period from 35 to 141 days (depending on the initial state of the wounds). The average hospital stay was 22.6 ± 2.4 days.

Discussion. It is known that human epithelial cells (hECs) and human mesenchymal stem cells (hMSCs) suppress proliferation, production of inflammatory cytokines and differentiation of T cells. At the same time, they stimulate the formation of regulatory T cells (Tregs). Soluble factors secreted by hECs, including PGE2, TGF-β, Fas-L, AFP, MIF, TRAIL and HLA-G, block differentiation of dendritic cells and M1 macrophages and promote differentiation of monocytes into the anti-inflammatory M2 phenotype. Moreover, hECs and hMSCs are known to be responsible for modulating the host immune system, mainly by suppressing TNF-α, IFN-γ, MCP-1 and IL-6 and increasing the level of anti-inflammatory cytokines. In vitro and in vivo results show increased cell migration and epithelialization leading to accelerated wound healing.

References

  1. Shapoval SD, Riazanov DYu, Savon IL, Bereznytskyi YaS. Khirurhichna klasyfikatsiia uskladnenoho syn dromu diabetychnoi stopy [Surgical Classification of Complicated Diabetic Foot Syndrome]. Proceedings of the XІІ ànnual scientific-practical conference with international participation “Rany i vyrazky, ranova in fektsiia, stopa diabetyka. Plastyka ta elektrozvariuvannia zhyvykh tkanyn”; 2012 Nov 29-30; Kyiv, Ukraine. (Klin Khir. 2012;(11):38.). Ukrainian.
  2. Shapoval SD, Savon IL, Vasylevska LA, Maksymova OO, Slobodchenko LYu. [The role of a gram–positive microflora and its resistance in purulent–necrotic complications in patients, suffering syndrome of diabetic foot]. Klin Khir. 2019 October;86(10):38-41. Ukrainian. https://doi.org/10.26779/2522-1396.2019.10.38
  3. Shapoval SD, Savon IL, Tribushnoy OV, Slobodchenko LYu. Osoblyvosti antybakterialnoi terapii khvorykh na uskladnenyi syndrom diabetychnoi stopy ta z proiavamy sepsysu [Features of Antibiotic Therapy for Patients with Complicated Diabetic Foot Syndrome and Sepsis]. Galician medical journal. 2016; 23(3 Supl 3):94-97. Ukrainian.
  4. Shapoval SD, Tribushnyi OV, Savon ІL. [Lethality in patients with complicated diabetic foot syndrome and signs of sepsis in accordance to recommendations «Sepsis–3»]. Klin Khir. 2018;85(3):33-34. Ukrainian. https://doi.org/10.26779/2522 1396.2018.03.33
  5. Besedin AM. [Reparation effects of vacuum wound therapy in patients with diabetic foot syndrome]. Medicni Perspektivi. 2015;20(3):106-112. Ukrainian.
  6. Herasymchuk PO, Deikalo IM, Vlasenko VH, Fira DB, Pavlyshyn AV. Vykorystannia vakuum-terapii v likuvanni ran u khvorykh na syndrom diabetychnoi stopy [Use of vacuum therapy in the treatment of wounds in patients with diabetic foot syndrome]. International Journal of Endocrinology. 2016;2(74):124-129. Ukrainian.
  7. Boyko VV, Ivanova YV, Mushenko YV, Korobov AM. Kompleksnoe lechenie oslozhnennoy khirurgicheskoy infektsii, vyzvannoy multirezistentnoy mikrobnoy floroy, u bolnykh s sindromom diabeticheskoy sto py [Combined therapy of complicated surgical infections caused by multi-drug resistant microflora in pa tients with diabetic foot]. Photobiology and photomedicine. 2016;12(1-2):51-59. Russian.
  8. Loosemore TM, Chalmers TC, Dormandy JA. A meta-analysis of randomized placebo control trials in Fontaine stages III and IV peripheral occlusive arterial disease. Int Angiol. 1994 Jun;13(2):133-142.
  9. Mitish VA, Pakhalova IuS, Eroshkin IA, Galstian GR, Blatun LA. [Pyo-necrotic injuries in case of the neuro-ischemic form of diabetic foot syndrome]. Khirurgiia (Mosk). 2014;(1):48-53. Russian.
  10. Besedin AM, Karpenko LI, Maluk YY, Pundyk GN, Sotnikov SV. Zastosuvannia optymizovanoi VAC-terapii u khvorykh iz hniino-nekrotychnymy uskladnenniamy syndromu diabetychnoi stopy [Using optimized VAC–wound therapy in patients with purulent necrotic complications of diabetic foot syndrome]. Klin Khir. 2015;(11.2):65-69. Ukrainian.
  11. Horobeiko MB, Krushynska ZH. [Systematic review of the effectiveness of topical treatment for ulcers in diabetic foot syndrome from the perspective of evidence-based medicine]. International Journal of Endocrinology. 2015;3(67):140-147. Ukrainian.
  12. Zaremba VS, Fedchyshyn NR, Bokhonko RL, Herych HI. [Some aspects to diagnosis and treatment of diabetic foot syndrome]. Shpytalna khirurhiia. 2019; 4:63-66. Ukrainian. https://doi.org/10.11603/ 2414-4533.2019.4.10712
  13. Galstyan GR, Sergeeva SV, Ignat’eva VI, Aksent’eva MV, Dedov II. [Clinical and economical grounds of budgetary quotation for patients with diabetic foot syndrome]. Diabetes mellitus. 2013;16(3):71-83. Russian. https://doi.org/10.14341/2072-0351-820
  14. Kalachev EV, Butirskiy AG, Vlasov NV. Osobennosti khirurgicheskoy infektsii pri gnoyno-nekroticheskikh oslozhneniyakh sindroma diabeticheskoy stopy [The features of surgical infection with septic and necrosis complications of diabetic foot syndrome]. Suchasni medychni tekhnolohii. 2013;(3(19)):68-70. Russian.
  15. Chaika OO, Buka GY, Vodianik RV, Glazunov VK, Nekrasov SYu, Kononenko DA, Chaika OO. Khirurgicheskaya taktika pri lechenii bolnykh s gnoyno-vospalitelnymi oslozhneniyami pri sindrome diabeticheskoy stopy [A surgery tactic of patients treatment with festering-inflammatory complications of syndrome of diabetic foot]. Ukrainskyi zhurnal ekstremalnoi medytsyny imeni H.O.Mozhaieva. 2011;12(3):103-105. Russian.
  16. Shor NA. [Surgical policy in diabetic angiopathies of lower limbs with pyonecrotic lesions]. Khirurgiia (Mosk). 2001;(6):29-33. Russian.
  17. Balabolkin MI, Klebanova EM, Kreminskaya VM. Patogenez i mekhanizmy razvitiya angiopatiy pri sakharnom diabete [Pathogenesis and angiopathies development mechanisms in diabetes mellitus]. Kardiologiia. 2000;40(10):74-87. Russian.
  18. Gorobeiko MB. [Silent ischemia of lower extremities in patients with diabetic peripheral polyneuropathy without pathosis of large arteries]. Clinical Endocrinology Endocrine Surgery. 2016;(3 (55)):60-64. Ukrainian.
  19. Gorobeiko MB. [Diabetic foot syndrome: farfetched or real threat?]. Clinical Endocrinology Endocrine Surgery. 2017;(1(57)):81-89. Ukrainian.
  20. Paggiaro AO, Menezes AG, Ferrassi AD, De Carvalho VF, Gemperli R. Biological effects of amniotic membrane on diabetic foot wounds: a systematic review. J Wound Care. 2018 Feb 1;27(Sup2):S19-S25. https://doi.org/10.12968/jowc.2018.27.Sup2.S19
  21. Oesman I, Dhamar Hutami W. Gamma-treated placental amniotic membrane allograft as the adjuvant treatment of unresponsive diabetic ulcer of the foot. Int J Surg Case Rep. 2020;66:313-318. https://doi.org/10.1016/j.ijscr.2019.12.033
  22. Dhall S, Hoffman T, Sathyamoorthy M, Lerch A, Jacob V, Moorman M, Kuang JQ, Danilkovitch A. A Viable Lyopreserved Amniotic Membrane Modulates Diabetic Wound Microenvironment and Accelerates Wound Closure. Adv Wound Care (New Rochelle). 2019 Aug 1;8(8):355-367. https://doi.org/10.1089/wound.2018.0931
  23. Sun Y, Shi H, Yin S, Ji C, Zhang X, Zhang B, Wu P, Shi Y, Mao F, Yan Y, Xu W, Qian H. Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction. ACS Nano. 2018 Aug 28;12(8):7613-7628. https://doi.org/10.1021/acsnano.7b07643
  24. Yan KS, Gevaert O, Zheng GXY, Anchang B, Probert CS, Larkin KA, et al. Intestinal Enteroendocrine Lineage Cells Possess Homeostatic and Injury-Inducible Stem Cell Activity. Cell Stem Cell. 2017 Jul 6;21(1):78-90.e6. https://doi.org/10.1016/j.stem.2017.06.014
Published
2021-10-27
How to Cite
Ivanova, Y. V., Gramatiuk , S. M., Prasol, V. O., Miasoiedov, K. V., Zarudnyi, O. O., & Holtsev, K. A. (2021). Cell Technologies in the Treatment of Chronic Wounds in Patients with Diabetes Mellitus. Transplantation and Artificial Organs, (2 (03), 51-65. https://doi.org/10.30702/transpaorg/10_21.2710/1151-65/4.001.4
Issue
Transplantation and artificial organs №2(03) 2021
Section
SCIENTIFIC PUBLICATIONS